TR&D 3: NETWORK GUIDED MACHINE LEARNING ? PROJECT SUMMARY Powerful machine learning techniques, including recent advances in deep learning, promise to revolutionize our ability to predict biomedical outcomes and could one day replace people in tasks such as image analysis, medical diagnosis, and precision therapy. However, most machine learning methods result in ?black boxes? which do not provide the mechanistic understanding needed to control and repair biological systems in industrial and medical applications. Furthermore, machine learning models trained for high accuracy in one context, such as predicting drug responses of cell lines, often transfer poorly to other contexts such as predicting drug responses of patients. How can we gain both the predictive power of machine learning and the interpretability and transferability of mechanistic models of biology? Here we explore a series of complementary and innovative approaches to this question based on integrating machine learning models with biological networks. Specifically, we aim to use networks to: [Aim 1] Guide the transfer of predictive models of drug response from model systems to patients; [Aim 2] Apply machine learning models to genotype-phenotype prediction in genome-wide association studies; and [Aim 3] Use machine learning for patient diagnosis and clinical trial selection in precision medicine applications.
These aims are motivated by Driving Biomedical Projects focused on drug response prediction in cell lines and patients (Aim 1; DBPs 13,19), genome-wide association analysis of disease (Aim 2; DBPs 14-15,17), predicting patient outcomes in cancer and major depression (Aim 3; DBPs 8,16), and clinical trial design (Aim 3; DBP 18). Our methods will be made available as open source software and on prominent cloud-based biomedical data and computing environments (TPs 6,7) to support wide adoption. ?? ?? ??

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Biotechnology Resource Grants (P41)
Project #
2P41GM103504-11
Application #
9937490
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
11
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Wang, Sheng; Ma, Jianzhu; Zhang, Wei et al. (2018) Typing tumors using pathways selected by somatic evolution. Nat Commun 9:4159
Zhang, Wei; Ma, Jianzhu; Ideker, Trey (2018) Classifying tumors by supervised network propagation. Bioinformatics 34:i484-i493
Nikolayeva, Iryna; Guitart Pla, Oriol; Schwikowski, Benno (2018) Network module identification-A widespread theoretical bias and best practices. Methods 132:19-25
Zhang, Wei; Bojorquez-Gomez, Ana; Velez, Daniel Ortiz et al. (2018) A global transcriptional network connecting noncoding mutations to changes in tumor gene expression. Nat Genet 50:613-620
Reznik, Ed; Luna, Augustin; Aksoy, Bülent Arman et al. (2018) A Landscape of Metabolic Variation across Tumor Types. Cell Syst 6:301-313.e3
Huang, Justin K; Jia, Tongqiu; Carlin, Daniel E et al. (2018) pyNBS: a Python implementation for network-based stratification of tumor mutations. Bioinformatics 34:2859-2861
MacParland, Sonya A; Liu, Jeff C; Ma, Xue-Zhong et al. (2018) Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun 9:4383
Pai, Shraddha; Bader, Gary D (2018) Patient Similarity Networks for Precision Medicine. J Mol Biol 430:2924-2938
Ebhardt, H Alexander; Root, Alex; Liu, Yansheng et al. (2018) Systems pharmacology using mass spectrometry identifies critical response nodes in prostate cancer. NPJ Syst Biol Appl 4:26
Bui, Nam; Huang, Justin K; Bojorquez-Gomez, Ana et al. (2018) Disruption of NSD1 in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation. Mol Cancer Ther 17:1585-1594

Showing the most recent 10 out of 145 publications